Signaling domains of the interleukin 2 receptor

Cytokine

Volumn 14, Issue 2, 2001, Pages 63-77

  Gaffen, Sarah L ^a,b  

^a University of Colorado Anschutz Medical Campus   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Autoimmunity; Cytokine; Interleukin 2; Receptor; Signal transduction

Indexed keywords

CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; RECEPTOR SUBUNIT;

AUTOIMMUNITY; CELL CULTURE; IMMUNE RESPONSE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0035925887     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2001.0862     Document Type: Article

References (188)

1. Selective in vitro growth of T lymphocytes from normal human bone marrows
2. Activation of Jak/STAT proteins in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sézary syndrome
3. Constitutively activated Jak-STAT, pathway in T cells transformed with HTLV-I
4. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene
5. Cytokine and anti-cytokine therapy
6. Increases in CD4 lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection
7. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus
8. Rational interleukin 2 therapy for HIV positive individuals: Daily low doses enhance immune function without toxicity
9. Control of viremia and prevention of clinical AIDS in Rhesus monkeys by cytokine-augmented DNA vaccination
10. The use of antibodies against the IL-2 receptor in transplantation
11. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
12. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
13. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β
14. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
15. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis
16. IL-15 and IL-2: A matter of life and death for T cells in vivo
17. Control of homeostasis of CD8+ memory T cells by opposing cytokines
18. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
19. Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable environment
20. Structure of the human interleukin-2 receptor gene
21. Localization of the gene encoding the human interleukin-2 receptor on chromosome 10
22. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15
23. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor
24. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells
25. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor
26. Interleukin-2 receptor γ chain: A functional component of the IL-4 receptor
27. Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor
28. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4
29. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans
30. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain
31. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
32. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
33. Gene therapy for human SCID: Dreams become reality
34. Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation
35. Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signaling
36. Growth signal transduction by the human IL-2 receptor requires cytoplasmic tyrosines of the β chain and non-tyrosine residues of the γc chain
37. Soluble IL-2 receptor β and γ subunits: Ligand binding and cooperativity
38. Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells
39. Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfection
40. Interleukin-2 receptor β chain gene: Generation of three receptor forms by cloned human α and β cDNA's
41. Cloning of the γ chain of the human IL-2 receptor
42. The interleukin-2 receptor
43. Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: A fluorescence resonance energy transfer study
44. Mechanism of interleukin-2 signaling: Mediation of different outcomes by a single receptor and transduction pathway
45. T cell growth factor receptors. Quantitation, specificity, and biological relevance
46. Expression of the immunoglobulin J chain in a murine B lymphoma is driven by autocrine production of interleukin-2
47. Intracytoplasmic phosphorylation sites of Tac antigen (p55) are not essential for the conformation, function, and regulation of the human interleukin 2 receptora
48. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor
49. Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene
50. Induction of mouse p55 interleukin-2 receptor gene expression by IL-2 and IL-4 and characterization of its transcription initiation sites
51. T-cell-replacing factor (interleukin-5) induces expression of interleukin 2 receptors on murine splenic B cells
52. Interleukin-10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes
53. Control of IL-2 receptor-α expression by IL-1, tumor necrosis factor, and IL-2. Complex regulation via elements in the 5′ flanking region
54. HTLV-I tax induces cellular proteins that activate the κ B element in the IL-2 receptor α gene
55. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-α gene and type 1 HIV
56. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro
57. Interleukin-2, interleukin-2 receptor and interleukin-4 levels are elevated in the sera of patients with periodontal disease
58. IL-2R α on one cell can present IL-2 to IL-2R β/γ(c) on another cell to augment IL-2 signaling
59. Structural design and molecular evolution of a cytokine receptor superfamily
60. A restricted cytoplasmic region of the IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization
61. Interleukin 2-dependent phosphorylation of interleukin 2 receptors and other T cell membrane proteins
62. Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro
63. JAK-STAT signaling by cytokine receptors
64. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
65. Interaction of the IL-2Rβ and γc chains with Jak1 and Jak3: Implications for XSCID and XCID
66. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits
67. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells
68. Phosphorylation and activation of the Jak-3 kinase in response to interleukin-2
69. Delineation of regions of the Interleukin-2 (IL-2) receptor β chain important for association of Jak1 and Jak3
70. Identification of a variable region within the cytoplasmic tail of the IL-2 receptor β chain that is required for growth signal transduction
71. Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: Possible link with the c-myc induction pathway
72. Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: Activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation
73. Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation
74. The β-chain of the IL2 receptor (p70) is tyrosine-phosphorylated on YT and HUT-102B2 cells
75. Hematopoietic growth factors activate the tyrosine phosphorylation of distinct sets of proteins in interleukin-3-dependent murine cell lines
76. Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor β is tyrosine phosphorylated
77. Interleukin 2 (IL-2)-induced tyrosine phosphorylation of IL-2 receptor p75
78. The cytoplasmic domain of the IL-2 receptor β chain contains both unique and functionally redundant signal transduction elements
79. Signaling through the IL-2R β chain activates a STAT-5-like DNA binding activity
80. Distinct tyrosine residues within the interleukin-2 receptor β chain drive signal transduction specificity, redundancy, and diversity
81. Different interleukin 2 receptor β-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation
82. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 sigaling
83. Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway
84. The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation
85. PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine
86. Functional dissection of the cytoplasmic subregions of the IL-2 receptor β chain in primary lymphocyte populations
87. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc
88. Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line
89. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation
90. Interleukin-2 receptor common γ-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression
91. BCL-2 family: Regulators of cell death
92. Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization
93. Protein phosphatase 1α is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis
94. Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase
95. IL-2-induced cellular events
96. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway
97. An IL-2 receptor β subdomain that controls Bcl-X(L) expression and cell survival
98. SH2-dependent association of phosphatidylinositol 3′-kinase 85-kDa regulatory subunit with the interleukin-2 receptor β chain
99. Functional cooperation of the interleukin-2 receptor β chain and Jak1 in phosphatidylinositol 3-kinase recruitment and phosphorylation
100. The serine-rich cytoplasmic domain of the interleukin-2 receptor β chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation
101. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway
102. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
103. p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes
104. The mechanism of action of cyclosporin A and FK506
105. Target of rapamycin (TOR): Balancing the opposing forces of protein synthesis and degradation
106. Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase
107. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
108. Uncoupling IL-2 signals that regulate T cell proliferation, survival and Fas-mediated activation-induced cell death
109. Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway
110. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells
111. Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells
112. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α
113. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase
114. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15
115. Identification and purification of human Stat proteins activated in response to IL-2
116. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15
117. Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes
118. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin-2 receptor β chain but is not essential for the proliferative signal transmission
119. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
120. SH2 domains recognize specific phosphopeptide sequences
121. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines
122. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon α, but not the T cell antigen receptor, in human T lymphocytes
123. Interaction of the IL-2 receptor with the src-family kinase p561ck: Identification of novel intermolecular association
124. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-1-infected human T cells
125. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor β chain
126. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling
127. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
128. Pleiotropic functions of IL-15 in innate and adaptive immunity
129. An IL-2 response element in the human IL-2 receptor α chain promoter is a composite element that binds Star5, Elf-1, HMG-I(Y) and a GATA family protein
130. An indirect effect of Stat5a in IL-2-induced proliferation: A critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction
131. Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor α gene
132. Functional association of Nmi with Star5 and Stat1 in IL-2- and IFNγ-mediated signaling
133. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain
134. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors
135. Autoimmunity as a consequence of retrovirus-mediated expression of c-FLIP in lymphocytes
136. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype
137. Naturally occurring dominant negative variants of Stat5
138. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation
139. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
140. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation
141. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells
142. Regulation of cell growth by IL-2: Role of STAT5 in protection from apoptosis but not in cell cycle progression
143. Inhibitors keep cytokines in check
144. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 2 and erythropoietin receptors
145. CIS associates with the interleukin-2 receptor β chain and inhibits interleukin-2-dependent signaling
146. A family of cytokine-inducible inhibitors of signalling
147. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
148. The role of Jak3 in lymphoid development, activation, and signaling
149. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3
150. Defective lymphoid development in mice lacking Jak3
151. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development
152. Janus kinase 3 (Jak3) is essential for common cytokine receptor γ chain (γ(c))-dependent signaling: Comparative analysis of γ(c), Jak3, and γ(c) and Jak3 double-deficient mice
153. The molecular role of the common γc subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes
154. The shared γc subunit within the human interleukin-7 receptor complex: A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency
155. Heteromerization of the γ(c) chain with the interleukin-9 receptor a subunit leads to STAT activation and prevention of apoptosis
156. Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor γc chain for Janus kinase activation leading to T cell proliferation
157. Role of the common cytokine receptor γ chain (γc) in thymocyte selection
158. Critical role of the interleukin 2 (IL-2) receptor γ-chain-associated JAK3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction
159. Differential requirement of the cytoplasmic subregions of γc chain in T cell development and function
160. IL2RGbase: A database of γ c-chain defects causing human X-SCID
161. A membrane-proximal region of the interleukin-2 receptor γc chain sufficient for Jak kinase activation and induction of proliferation in T cells
162. IL-2-induced signal transduction: Involvement of tyrosine kinase and IL-2 receptor γ chain
163. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor α subunit
164. High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells
165. Down-regulation of high affinity interleukin 2 receptors in a human tumor T cell line. Interleukin 2 increases the rate of surface receptor decay
166. Selection of internalization-deficient cells by interleukin-2-Pseudomonas exotoxin chimeric protein: The cytoplasmic domain of the interleukin-2 receptor β chain does not contribute to internalization of interleukin-2
167. Endocytosis of the common cytokine receptor γc chain. Identification of sequences involved in internalization and degradation
168. T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor γ c chain in a severe combined immune deficiency X1 patient
169. A soluble form of the murine common γ chain is present at high concentrations in vivo and suppresses cytokine signaling
170. Functional cleavage of the common cytokine receptor γ chain (γc) by calpain
171. Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: Implications for redundancy and pleiotropism in cytokine signal transduction
172. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway
173. Identification of a novel immunoreceptor tyrosine-based activation motif-containing molecule, STAM2, by mass spectrometry and its involvement in growth factor and cytokine receptor signaling pathways
174. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction
175. Cloning of a novel signal-transducing adaptor molecule containing an SH3 domain and ITAM
176. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells
177. IL-2 Induced signal transduction involves the activation of nuclear NF-κB expression
178. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
179. Cytokine-stimulated T lymphocyte proliferation is regulated by p27(Kip1)
180. Promoter activity of the proliferating-cell nuclear antigen gene is associated with inducible CRE-binding proteins in interleukin 2-stimulated T lymphocytes
181. Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines
182. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes
183. Immunoglobulin secretion and phosphorylation of common proteins are induced by IL-2, IL-4, and IL-6 in the factor responsive human B cell line, SKW6.4
184. A model system for peptide hormone action in differentiation: Interleukin-2 induces a B lymphoma to transcribe the J chain gene
185. Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (STAT) 5 activation of two enhancers
186. IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells
187. Interleukin-2 and the interleukin-2 receptor complex
188. Receptor/ligand superfamilies: Emerging families of cytokines and receptors